Soros Fund Management Raises Stake in PlasmaTech Biopharmaceuticals (PTBI) to 5.17%

In a 13G filing on PlasmaTech Biopharmaceuticals (NASDAQ: PTBI), hedge fund Soros Fund Management disclosed a 5.17%, or 1,166,667 share, stake in the company. This is up 366.67% from the 250,000 shares held at the end of the latest quarter ending Dec. 31, 2014.

For more notable holders of PlasmaTech Biopharmaceuticals stock click here. For more information on Soros Fund Management click here.

You May Also Be Interested In

• Ackman Confirms 19.8% Stake in Hertz Global (HTZ)
• Pershing Square Capital Discloses 12.7M Share Stake In Hertz (HTZ) - Filing
• Under Armour (UA) Appoints Dawn N. Fitzpatrick, Eugene D. Smith, and Robert J. Sweeney to its Board